Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD

Christopher Reynolds, John Levine, Joseph Uberti, Voravit Ratanatharathorn, Lois Ayash, Samuel Silver, Gregory Yanik, Pavan Reddy, Kenneth Cooke, Michael Becker, Raymond Hutchinson, James Ferrara

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)78-79
Number of pages2
JournalJournal of Supportive Oncology
Volume3
Issue number2 SUPPL. 1
StatePublished - Mar 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Reynolds, C., Levine, J., Uberti, J., Ratanatharathorn, V., Ayash, L., Silver, S., Yanik, G., Reddy, P., Cooke, K., Becker, M., Hutchinson, R., & Ferrara, J. (2005). Keratinocyte growth factor (palifermin) in combination with tacrolimus and methotrexate for the prevention of acute graft-vs-host-disease (AGVHD) in patients at high risk of AGVHD. Journal of Supportive Oncology, 3(2 SUPPL. 1), 78-79.